department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

CLEOCIN · pharmadog

pharmadog
drugs
CLEOCIN

drug · small molecule

patient view →

CLEOCIN

Marketedupdated 2mo ago

by $PFE PFIZER INC🔗 ChEMBL

Approved

community read0 votes

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 17 approved and 3 investigational indications.

indications

investigational

COPD

targets

Bacterial 70S ribosome

all catalysts(100)

approval · 100

view all 100 catalysts →

News(0)

no news has mentioned this drug yet

brand

CLEOCIN

trade names

Cleocin, Cleocin phosphate, Cleocin t, Clinadac, Clinda-derm, Clindac

generic

CLINDAMYCIN PHOSPHATE

MOA

Mechanism of Action Clindamycin inhibits bacterial protein synthesis by binding to the 23S RNA of the 50S subunit of the ribosome. Clindamycin is bacteriostatic.

phase

marketed

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN T (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN T (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN T (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN T (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN T (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN T (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN T (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN T (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN T (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN T (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN T (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN T (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN T (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN T (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN T (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN T (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN T (CLINDAMYCIN PHOSPHATE) — FDA approval

🐶 often sniffed alongside

top 8

tagApproval684 co-mentions · 217 sources
drugCLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER595 co-mentions · 220 sources
drugCLEOCIN PHOSPHATE595 co-mentions · 220 sources
drugCLEOCIN T595 co-mentions · 220 sources
drugCLEOCIN HYDROCHLORIDE430 co-mentions · 215 sources
drugclindamycin345 co-mentions · 220 sources
drugClindamycin Phosphate Hikma255 co-mentions · 130 sources
drugOklarin255 co-mentions · 130 sources

Patent cliff

source: FDA Orange Book

first barrier falls

Dec 2, 2026

148 days

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (3)

Sep 22, 2036method-of-use (U-3293)US 11129896
Sep 22, 2036formulationUS 12303563
Dec 2, 2026formulationUS 9789057148d

FDA exclusivities (2)

Dec 7, 2029GAINGAIN Antibiotic (5y)3.4y
Dec 7, 2024NPNP

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

openFDA · ClinicalTrials.gov · OpenTargets

last refreshed 51m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

$PFE24.32+1.84%

Trials studying CLEOCIN

phase4Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreonot yet recruitingn=100
—Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne Vulgarisactive not recruitingn=200
EP1Experience With Topical Acne Treatmentactive not recruitingn=72
phase1Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgariscompletedn=550
phase1A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel for the Treatment of Acne Vulgaris.completedn=382
phase1Clindamycin 300 mg Capsules in Healthy Subjects Under Fasting Conditionscompletedn=24
phase1Clindamycin 300 mg Capsules in Healthy Subjects Under Fed Conditionscompletedn=24